Verified Insights
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
+91 9425150513 (Asia) support@24lifesciences.com
+91 9425150513 (Asia) support@24lifesciences.com
Download Sample Pdf
MARKET INSIGHTS
The Global Peripherally Inserted Central Catheters market was valued at USD 516 million in 2024. The market is projected to grow from USD 541 million in 2025 to USD 736 million by 2031, exhibiting a CAGR of 5.1% during the forecast period.
A Peripherally Inserted Central Catheter (PICC) is a long, flexible tube that is inserted into a peripheral vein, typically in the upper arm, and then advanced until its tip is positioned in a large central vein near the heart. This device is a cornerstone of modern vascular access, providing a critical pathway for administering medications, fluids, nutrition, or for drawing blood over extended periods, ranging from weeks to months. It is particularly valuable for patients requiring long-term intravenous therapy because it offers a less invasive alternative to other central venous catheters. However, its use requires vigilant maintenance and monitoring to mitigate risks such as infection or thrombosis.
The market's steady growth is driven by several key factors, including the rising prevalence of chronic diseases requiring long-term drug administration, an aging global population, and a strong preference for minimally invasive procedures. The expansion of outpatient and home care settings is also a significant contributor, as PICCs are well-suited for these environments. Furthermore, technological advancements aimed at reducing catheter-related complications, such as antimicrobial coatings and valve technologies, are enhancing product adoption. The competitive landscape features major players like BD, Teleflex, and B. Braun, who continuously invest in research and development and engage in strategic initiatives to strengthen their market positions globally.
Rising Prevalence of Chronic Diseases and Growing Geriatric Population
The increasing global burden of chronic conditions such as cancer, cardiovascular diseases, and renal failure is a primary driver for the Peripherally Inserted Central Catheters (PICC) market. These patients often require long-term venous access for therapies like chemotherapy, antibiotic regimens, and parenteral nutrition. Concurrently, the expanding geriatric population, which is more susceptible to such illnesses, significantly boosts the demand for PICC lines as a safer alternative to repeated peripheral insertions.
Advantages Over Traditional Central Venous Catheters
PICCs offer distinct clinical benefits, including a lower risk of procedural complications like pneumothorax compared to centrally inserted catheters. Their insertion by specially trained nurses or radiologists at the bedside or in an outpatient setting reduces costs and increases patient comfort. The growing preference for minimally invasive procedures among both healthcare providers and patients further propels market adoption.
➤ The global shift towards home-based healthcare is expanding the application of PICCs, supported by technological advancements in catheter design that enhance safety and longevity.
Technological innovations, such as the development of power-injectable PICCs, antimicrobial coatings, and ultrasound-guided insertion techniques, have improved the safety profile and functionality of these devices. These enhancements reduce the incidence of catheter-related bloodstream infections (CRBSIs) and occlusions, making PICCs a more reliable option for a wider range of clinical applications.
MARKET CHALLENGES
Risk of Complications and Associated Costs
Despite their advantages, PICCs are associated with significant clinical challenges, primarily the risk of complications such as deep vein thrombosis (DVT), catheter-related bloodstream infections (CRBSI), and mechanical issues like occlusion or migration. Managing these complications increases the overall cost of care and can lead to extended hospital stays, posing a substantial challenge for healthcare systems focused on cost containment.
Other Challenges
Regulatory Hurdles and Reimbursement Issues
The market faces stringent regulatory requirements for device approval, which can delay product launches. Furthermore, variability in reimbursement policies for PICC insertion and maintenance across different regions and insurance providers can limit market growth and create financial barriers for both providers and patients.
Need for Specialized Training
Successful and safe PICC insertion requires specialized training and competency validation for clinicians. The lack of standardized training programs and the associated costs and time for training can be a barrier to widespread adoption, particularly in resource-limited settings.
Stringent Regulatory Frameworks
The medical device industry is governed by rigorous regulatory standards from bodies like the US FDA and the European Medicines Agency. The process for obtaining approval for new PICC devices or significant modifications is lengthy and costly. This acts as a major restraint, particularly for smaller manufacturers, potentially slowing the pace of innovation and market entry of new products.
Competition from Alternative Vascular Access Devices
The PICC market faces competition from other central venous access devices, such as tunneled catheters and implanted ports. For patients requiring very long-term access, implanted ports are often preferred due to a lower risk of infection. The availability of these alternatives can restrain the growth of the PICC market in certain patient populations.
Expansion in Emerging Markets
Emerging economies in Asia-Pacific, Latin America, and the Middle East present significant growth opportunities. Improving healthcare infrastructure, rising healthcare expenditure, and increasing awareness of advanced medical devices in these regions are expected to drive the adoption of PICC lines. Market players can capitalize on this by expanding their distribution networks and offering cost-effective solutions.
Technological Innovation and Product Development
There is a substantial opportunity for growth through continued innovation. Developing PICCs with enhanced materials to reduce thrombogenicity, integrating sensor technology for real-time monitoring, and creating pediatric-specific designs are key areas. Innovations that demonstrably lower complication rates will be highly valued by healthcare providers.
Growing Emphasis on Outpatient and Home Care
The strong trend towards shifting care from inpatient to outpatient and home settings is a major opportunity. PICCs are ideally suited for this model, enabling the administration of complex therapies outside the hospital. Companies that develop support systems, educational tools, and monitoring technologies for home-based PICC care are well-positioned to capture this expanding market segment.
Segment Analysis:| Segment Category | Sub-Segments | Key Insights |
| By Type |
|
Valve Type catheters are the dominant force in the market, primarily due to their enhanced safety features such as integrated valves that reduce the risk of blood backflow and air embolism. This design is particularly favored for long-term therapies like chemotherapy and prolonged antibiotic administration, as it minimizes the need for frequent line maintenance. Manufacturers are heavily invested in R&D for this segment, focusing on advanced material coatings that provide superior biocompatibility and further reduce the incidence of catheter-related complications, making them the preferred choice in sophisticated hospital settings. |
| By Application |
|
Adult applications represent the most substantial segment, driven by the high prevalence of chronic diseases such as cancer, which require extended intravenous therapies in the aging global population. The demand is robust in both inpatient and increasingly popular outpatient and home care settings, as healthcare systems aim to reduce hospitalization costs. While the pediatric segment is smaller, it presents critical specialized requirements, including smaller catheter sizes and enhanced safety features for delicate veins, creating niche opportunities for manufacturers focused on specialized vascular access solutions. |
| By End User |
|
Hospitals remain the primary end users, where the majority of complex PICC insertions and management for critical care and long-term treatments occur. These facilities have the necessary specialized personnel and equipment for safe placement. There is, however, a noticeable and accelerating trend of adoption in Home Care Settings, fueled by the global shift towards cost-effective and patient-preferred decentralized care models. This transition is encouraging manufacturers to develop PICCs that are easier for patients and caregivers to manage outside of traditional clinical environments. |
| By Material |
|
Polyurethane is the leading material category due to its excellent balance of flexibility, durability, and cost-effectiveness, making it suitable for a wide range of patient needs. Silicone is highly valued for its superior biocompatibility and softness, which is crucial for long-term indwelling catheters to minimize vessel irritation. The most significant innovation driver is the segment of Advanced Coated Materials, which includes antimicrobial and antithrombotic coatings. These advanced materials are becoming a key differentiator for premium product lines, directly addressing major clinical concerns like infection and thrombosis. |
| By Insertion Technology |
|
Ultrasound-Guided insertion is the leading and fastest-evolving segment, as it significantly improves the success rate and safety of PICC placement by providing real-time visualization of veins. This technology reduces complications such as accidental arterial puncture and is becoming the standard of care in well-equipped healthcare facilities. While the Traditional Anatomical Landmark method is still used, its application is declining in favor of more precise techniques. The ongoing development of other advanced modalities, including navigation systems, promises further enhancements in placement accuracy, particularly for patients with difficult vascular access. |
A Consolidated Market Driven by Innovation, Safety, and Strategic Moves
The global Peripherally Inserted Central Catheters (PICC) market is characterized by the dominance of a few established medical device giants, with BD (Becton, Dickinson and Company), Teleflex, and B. Braun leading the competitive landscape. These players leverage strong brand recognition, extensive R&D capabilities, and comprehensive product portfolios to maintain significant market share. Competition is intense and primarily revolves around technological innovation, particularly in catheter design, safety features to minimize bloodstream infections and thrombosis, and the development of advanced material coatings like antimicrobial and antithrombotic surfaces. Valve-type catheters are a major focus area for these leaders, offering benefits such as reduced risk of blood reflux and air embolism. Strategic activities, including mergers, acquisitions, and partnerships, are common as companies seek to broaden their geographic reach and strengthen their technological offerings.
Beyond the top-tier multinationals, a number of mid-sized and specialized companies compete effectively in specific niches. Players such as AngioDynamics, Cardinal Health, and Vygon offer robust alternatives, often competing on factors like cost-effectiveness, product reliability, and specialized applications, including pediatric PICCs. Emerging manufacturers, particularly from the Asia-Pacific region like Foshan Special Medical and Zhengzhou DIALL Medical Technology, are gaining traction by providing competitively priced open-end type catheters, catering to the cost-sensitive segments of the market and meeting the growing demand in developing healthcare systems. This dynamic creates a competitive environment where established players defend their positions with advanced technologies, while challengers erode market share through targeted solutions and regional strengths.
List of Key Peripherally Inserted Central Catheters Companies ProfiledBD (Becton, Dickinson and Company)
AngioDynamics
B. Braun
Vygon
Argon Medical
Medcomp
Health Line
Branden
Foshan Special Medical
Shandong Ande Healthcare Apparatus
The global Peripherally Inserted Central Catheters (PICC) market is on a steady growth trajectory, with its valuation reaching 516 million in 2024 and projected to expand to US$ 736 million by 2031, representing a compound annual growth rate (CAGR) of 5.1%. This growth is underpinned by the critical role of PICCs, which are long, flexible tubes inserted into a peripheral vein in the upper arm and advanced to a central vein. They are essential for providing long-term intravenous access for medications, fluids, nutrition, and blood draws, offering a less invasive alternative for patients requiring extended treatment ranging from weeks to months.
Other TrendsRegional Market Expansion
North America continues to be the primary driver of the PICC market, supported by its advanced healthcare infrastructure, widespread adoption of innovative vascular access devices, and favorable reimbursement policies. Europe follows closely, with a growing emphasis on outpatient and home care solutions that increase the demand for reliable, long-term venous access. The Asia-Pacific region is emerging as a high-potential market, fueled by significant healthcare investments, a large patient population with chronic diseases, and increasing demand for minimally invasive procedures. Latin America and the Middle East & Africa, while smaller in market share, are showing growing interest in PICC adoption as healthcare standards improve globally.
Intensifying Competitive Landscape and Technological InnovationThe competitive landscape of the PICC market is characterized by intense rivalry among established medical device companies. Key players such as BD (Becton, Dickinson and Company), Teleflex, B. Braun, and AngioDynamics focus on developing advanced valve-based catheters and specialized material coatings to enhance safety and reduce infection risks. Mid-sized and emerging manufacturers are increasingly competing by offering cost-effective open-end PICCs and specialized pediatric lines. This competition drives continuous research and development, as well as strategic partnerships and acquisitions, as companies strive to strengthen their market positions and expand their global footprints in response to the escalating demand for clinician-friendly insertion techniques and superior patient outcomes.
Regional Analysis: Peripherally Inserted Central Catheters MarketEurope
Europe represents a significant and well-established market for Peripherally Inserted Central Catheters, characterized by varying levels of adoption and healthcare system maturity across its nations. Western European countries, such as Germany, France, and the United Kingdom, demonstrate high utilization rates, supported by robust public healthcare infrastructure and growing emphasis on outpatient and home-based care models, for which PICCs are ideally suited. The region benefits from stringent regulatory oversight via the CE marking process, ensuring product safety and quality. However, market dynamics are influenced by cost-containment pressures from national health services, which can impact the speed of adoption for premium-priced, technologically advanced PICC products. There is a noticeable trend towards the formation of dedicated vascular access teams in major hospitals, mirroring the North American model, which is improving procedural standards and patient outcomes. The diverse reimbursement landscape across the European Union creates a patchwork of adoption patterns, with more unified clinical guidelines from European societies helping to drive standardization and best practices.
Asia-Pacific
The Asia-Pacific region is identified as the fastest-growing market for PICCs, fueled by rapidly expanding healthcare infrastructure, increasing healthcare expenditure, and a growing burden of chronic diseases requiring long-term intravenous therapy. Countries like China, Japan, India, and Australia are key contributors to this growth. Japan boasts a highly advanced medical device market with early adoption of innovative technologies, while China's market is expanding rapidly due to healthcare reforms and increasing investments in hospital facilities. The region presents a mix of mature and emerging markets, leading to diverse clinical practices and varying levels of awareness about PICC benefits. A significant driver is the rising number of trained healthcare professionals specializing in vascular access, although access to these specialists can be uneven outside major urban centers. Cost sensitivity remains a key factor, with price competition among both international and local manufacturers influencing product selection and market penetration strategies across different countries.
South America
The South American PICC market is in a developing phase, with growth potential largely concentrated in major economies such as Brazil and Argentina. Market expansion is primarily driven by gradual improvements in public and private healthcare systems and an increasing focus on improving patient safety and reducing hospital-acquired infections, which PICCs can help achieve when managed correctly. However, the market faces challenges, including economic volatility affecting healthcare budgets, limited reimbursement coverage for advanced medical devices, and a scarcity of specialized vascular access teams in many areas. Adoption is often highest in large, private hospitals in urban centers, which have better access to technology and trained personnel. There is a growing recognition of the clinical and economic benefits of PICCs for medium-duration therapies, but widespread adoption hinges on increased professional training, greater investment in healthcare infrastructure, and more supportive healthcare policies across the continent.
Middle East & Africa
The Middle East and Africa region exhibits a highly heterogeneous PICC market. The Gulf Cooperation Council (GCC) countries, such as the United Arab Emirates and Saudi Arabia, represent the most advanced sub-markets, characterized by state-of-the-art healthcare facilities, high per capita healthcare spending, and a strong presence of international medical device companies. These countries are early adopters of advanced PICC technologies. In contrast, many parts of Africa face significant challenges, including limited healthcare infrastructure, budget constraints, and a shortage of specialized healthcare professionals trained in PICC insertion and management. Market growth in the region is therefore uneven, driven predominantly by the affluent Middle Eastern nations. Initiatives to improve healthcare access and quality in certain African countries present long-term growth opportunities, but the market remains nascent outside of key urban medical centers, with adoption heavily influenced by economic development and healthcare investment levels.
This market research report offers a holistic overview of global and regional markets for the forecast period 2025–2032. It presents accurate and actionable insights based on a blend of primary and secondary research.
✅ Market Overview
Global and regional market size (historical & forecast)
Growth trends and value/volume projections
✅ Segmentation Analysis
By product type or category
By application or usage area
By end-user industry
By distribution channel (if applicable)
✅ Regional Insights
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country-level data for key markets
✅ Competitive Landscape
Company profiles and market share analysis
Key strategies: M&A, partnerships, expansions
Product portfolio and pricing strategies
✅ Technology & Innovation
Emerging technologies and R&D trends
Automation, digitalization, sustainability initiatives
Impact of AI, IoT, or other disruptors (where applicable)
✅ Market Dynamics
Key drivers supporting market growth
Restraints and potential risk factors
Supply chain trends and challenges
✅ Opportunities & Recommendations
High-growth segments
Investment hotspots
Strategic suggestions for stakeholders
✅ Stakeholder Insights
This report is designed to support strategic decision-making for a wide range of stakeholders, including:
Medical device manufacturers
Healthcare providers and hospital systems
Investors and venture capitalists
Research institutions and academic centers
Policy makers and regulatory bodies
-> Global Peripherally Inserted Central Catheters market was valued at USD 516 million in 2024 and is expected to reach USD 736 million by 2031.
-> Key players include BD, Teleflex, B. Braun, AngioDynamics, and Cardinal Health, among others.
-> Key growth drivers include rising prevalence of chronic diseases, aging population, and preference for minimally invasive procedures.
-> North America remains the dominant market, while Asia-Pacific shows fastest growth.
-> Emerging trends include antimicrobial coatings, valve technologies, and expansion of outpatient care solutions.
Our Clients
“The data provided by 24LifeScience was clear, well-organized, and useful for internal strategy planning. It helped us understand the competitive landscape more effectively.”
“We used one of their market overview reports for early-stage feasibility work. It gave us a helpful snapshot of current trends and key players in our therapeutic area.”
“I appreciated the team’s responsiveness and willingness to adjust the scope based on our feedback. The final report was aligned with our expectations and timelines.”
“Their custom report on clinical trial trends was a helpful reference as we explored new indications."
“As someone working on early product planning, I found their therapeutic area briefs quite useful. The information was presented in a way that made it easy to extract key takeaways.”
“We didn’t need anything overly complex—just solid, dependable data. 24LifeScience delivered exactly that, without unnecessary fluff.”
“Their reports gave us a good foundation to start our own market assessment. While we supplemented it with other data, this was a great starting point.”
“I’ve used a few of their reports for academic and grant writing purposes. They’re generally well-cited and reliable for understanding market scope.”
At 24LifeScience, we combine domain expertise with dependable research delivery. What truly differentiates us isn't just what we do — it's how we do it. Our clients trust us because we offer consistency, security, value, and most importantly, insight that drives action.
Precision-driven research you can trust. We uphold rigorous data validation processes to ensure every report is reliable and based on credible sources.
We uphold rigorous data validation processes to ensure every report is reliable, up-to-date, and based on credible sources.
24LifeScience powers research for top firms in 20+ nations.Chosen by leading life sciences companies worldwide.
We offer competitive pricing models that align with your project scope — no hidden charges, no lock-in. Tailored pricing for every scale and need.
8–10+ years of life sciences expertise turned into strategic insights.We don’t just summarize data we contextualize it.
Whether it's a ready-made report or a custom project, we deliver within the promised timeline With real-time updates